Sangamo Therapeutics (SGMOQ) Cash & Equivalents (2010 - 2025)
Sangamo Therapeutics' Cash & Equivalents came in at $20.95 million for Q4 2025, down 50.0% from $41.92 million a year earlier and down 29.3% from the prior quarter.
Sangamo Therapeutics (SGMOQ) Cash & Equivalents (2010 - 2025) Analysis & Trends
Going back to Q2 2010, Sangamo Therapeutics' Cash & Equivalents data covers 63 quarters.
- Cash & Equivalents has declined in each of the last four years, with a five-year compound annual growth rate of -30.7% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $41.92 million in FY2024 (-7.3%), $45.2 million in FY2023 (-55.0%), $100.44 million in FY2022 (-43.8%) and $178.87 million in FY2021 (+36.2%).
- The Q4 2025 figure represents the lowest quarterly Cash & Equivalents since Q1 2017.
- Year-over-year, Cash & Equivalents increased in 1 of the last eight quarters, with an average decline of 27.1%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2021 (growth of 43.4%), and the weakest in Q2 2021 (a decline of 63.7%).
- Business Quant data shows SGMOQ's Cash & Equivalents at $29.62 million (Q3 2025), $38.34 million (Q2 2025) and $25.2 million (Q1 2025) in the three quarters before Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Sangamo Therapeutics | 42.03 Mn | -72.08 Mn | - | 20.95 Mn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 20.95 Mn |
| Sep 30, 2025 | 29.62 Mn |
| Jun 30, 2025 | 38.34 Mn |
| Mar 31, 2025 | 25.20 Mn |
| Dec 31, 2024 | 41.92 Mn |
| Sep 30, 2024 | 39.20 Mn |
| Jun 30, 2024 | 27.79 Mn |
| Mar 31, 2024 | 54.42 Mn |
| Dec 31, 2023 | 45.20 Mn |
| Sep 30, 2023 | 56.51 Mn |
| Jun 30, 2023 | 66.83 Mn |
| Mar 31, 2023 | 78.24 Mn |
| Dec 31, 2022 | 100.44 Mn |
| Sep 30, 2022 | 94.57 Mn |
| Jun 30, 2022 | 117.71 Mn |
| Mar 31, 2022 | 120.26 Mn |
| Dec 31, 2021 | 178.87 Mn |
| Sep 30, 2021 | 176.95 Mn |
| Jun 30, 2021 | 169.88 Mn |
| Mar 31, 2021 | 122.98 Mn |
Sangamo Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();